Evidence map›Paper›PMID 31817940›Full record

ArticleInternational journal of molecular sciences2019

Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.

Mirko Manetti, Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, Serena Guiducci, Silvia Bellando-Randone, Erika Pigatto, Franco Cozzi, Lidia Ibba-Manneschi, Marco Matucci-Cerinic

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mirko ManettiSection of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Eloisa RomanoSection of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Irene RosaSection of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Bianca Saveria FiorettoSection of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Serena GuiducciSection of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Silvia Bellando-RandoneSection of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Erika PigattoRheumatology Unit, Department of Medicine - DIMED, University of Padova, 35128 Padova, Italy.
Franco CozziRheumatology Unit, Department of Medicine - DIMED, University of Padova, 35128 Padova, Italy.
Lidia Ibba-ManneschiSection of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Marco Matucci-CerinicSection of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In systemic sclerosis (SSc), the possible involvement of lymphatic microcirculation and lymphangiogenesis has traditionally been overshadowed by the greater emphasis placed on dysfunctional blood vascular system and angiogenesis. In the present in vitro study, we explore for the first time whether the SSc microenvironment may interfere with lymphangiogenesis, a complex, multi-step process in which lymphatic microvascular endothelial cells (LMVECs) sprout, migrate, and proliferate to generate new lymphatic capillaries. Normal human adult dermal LMVECs from three donors were treated with serum from SSc patients (

Indexed as

LymphangiogenesisTumor MicroenvironmentAdultApoptosisCase-Control StudiesCell MovementCell ProliferationCells, CulturedCulture Media, ConditionedEndothelial CellsFemaleHumansIn Vitro TechniquesMaleMiddle AgedNeovascularization, PathologicCulture Media, ConditionedFLT4 protein, humanNeuropilin-2neuropilin-2, humanVascular Endothelial Growth Factor Receptor-3dermal lymphatic microvascular endothelial cellslymphangiogenesisNRP-2sclerodermasystemic sclerosisVEGFR-3/Flt-4

Identifiers

PMID31817940
PMCPMC6940874
OpenAlexW2992473312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.